Cargando...
Ras Isoprenylation and pAkt Inhibition by Zoledronic Acid and Fluvastatin Enhances Paclitaxel Activity in T24 Bladder Cancer Cells
BACKGROUND: Bisphosphonates interfere with the mevalonate pathway and inhibit the prenylation of small GTP-binding proteins such as ras and rap. We hypothesized that zoledronic acid would synergistically inhibit T24 bladder cancer cell growth in combination with fluvastatin and paclitaxel. METHODS:...
Gardado en:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3756383/ https://ncbi.nlm.nih.gov/pubmed/24212635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers3010662 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|